COMMERCIAL

Product Specification Therapeutic Category
Acotiamide Hydrochloride Hydrate IH Antiemetic
Azelnidipine IH Antihypertensive
Bacitracin Zinc IP, BP, USP Anti Bacterial
Benfotiamine IH Vitamin B₁
Clindamycin Phosphate Antibiotic
Citicoline Monosodium IP Central Stimulant/Nootropic Agent
Gliclazide IP, BP Antidiabetic
Isotretinoin IP, BP, USP Anti-Acne
 Levosulpiride  IH  Antipsychotic
 Luliconazole Antifungal
 Oxaceprol  IH  Anti Inflammatory agent
 Prucalopride Succinate Prokinetic Agent
Teneligliptin Hydrobromide Hydrate IH Antidiabetic
Tretinoin BP, USP Anti-Acne
Ursodeoxy cholic Acid BP, EP, IP Choleretic agent

UNDER DEVELOPMENT

Product Therapeutic Category Current Status
 Fimasartan Trihydrate Potassium  Antihypertensive  Under Development
 Levetiracetam Antiepileptic  Under Development
 Montelukast Sodium  Antiasthmatic  Under Development
 Obeticholic Acid Gastrointestinal Agent  Under Development
 Phenylephrine HCl  Decongestant  Under Development
Rifaximin Antibacterial Under Development
Ticagrelor Anticoagulant Under Development
 Vildagliptin  Antidiabetic  Under Development

Note-Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement.

Please make your inquiry at sales@kimiabiosciences.com